COVID-19 Funding Opportunities

The availability of COVID-19 grants and funding opportunities to support research is  evolving.  Listed below are links to a collection of COVID-19 funding opportunities to support research from a variety of federal agencies, foundations, and organizations. Check back often for updated lists.

Please contact Lori Uttech-Hanson to share relevant funding sources at

Funding Opportunities Related to COVID-19

This is an accordion element with a series of buttons that open and close related content panels.

Grant Database Lists (Free Access to Collections of Funding Announcements)

Ex Libris Research Professional:  The Ex Libris Research Professional together with Pivot® funding services are providing free access to a list of select funding opportunities related to combatting the coronavirus and COVID-19. By raising awareness of these resources, which are offered from a wide range of global funders, they hope to help researchers expand their scholarly efforts to understand and contend with this global pandemic.
Link is:

Grant Forward: GrantForward has provided a free list of grants related to addressing COVID-19 ranging from small foundation to large-scale federal research grants in an effort to help researchers and others find science-based solutions to address this global pandemic.
Link is:

GrantStation: GrantStation’s list includes funding opportunities for nonprofits, small businesses, journalists, and artists.
Link is:

Pivot: Pivot has given free access to a list of COVID-19 related funding sources, and they are updating the list weekly.
Link is:

WI Center for Technology Commercialization: The CTC has posted a list of federal agencies that are supporting research and development in response to the coronavirus.  Many of these agencies are included in the panels below on this medRAMP website, with information on specific funding announcements.
Link is:

InnoCentive COVID-19 Challenges: This page is exclusively for Coronavirus related challenges.  Each challenge will have a specific problem area defined for either required Solutions or Ideas to be submitted. Clients from the public and private sectors will be named in the challenges as having provided support, funding and reviewing expertise for solutions submitted.
• Link is:

Agency for Healthcare Research and Quality

  • Special Emphasis Notice (SEN): AHRQ Announces Interest in Health Services Research to Address Substance Use Disorder Epidemic (NOT-HS-21-010): The purpose of this SEN is to inform the research community that the AHRQ is interested in receiving health services research grant applications to advance our nation’s understanding of the substance use disorder crisis and provide solutions for addressing it. In this SEN, AHRQ is interested in health services research to prevent, identify and treat substance use disorders with a high degree of interest in applications that respond to the following three specific areas of focus: (1) Dissemination and implementation of evidence-based, non-pharmacological and behavioral interventions that can treat multiple substances or polysubstance use in ambulatory care and primary care settings, with a particular interest in substances for which pharmacological treatments are not available. (2) Development and testing of healthcare services interventions in primary care and ambulatory care settings to address substance use disorder that consider the social, environmental, economic and psychological factors that contribute to substance use disorder.  Examples include care coordination, integration of substance use services in ambulatory care settings, or integration of population health approaches with primary care. Applications that take advantage of the natural experiment caused by the COVID-19 pandemic to examine how changes in service delivery (such as expanded use of telehealth) affect access to care, quality of care, and health inequities are particularly welcome. (3) Understanding and addressing the effect of substance use disorder on whole person health and the development and/or management of other chronic conditions. The Agency encourages research teams to submit applications in response to this emphasis using AHRQ’s standing R18, R03, and R01 funding mechanisms (PA-18-793PA-18-794PA-18-795). AHRQ also is interested in receiving career development awards (PA-20-067 and PA-17-232) that propose developing generalizable health service research skills through projects related to the substance use disorder crisis. Additionally, AHRQ has interest in receiving dissertation award grant proposals that relate to the substance use disorder crisis (PA-18-765).
    Due Date: Active until 3/15/2023
    Funding Amount: Varies by mechanism
  • General Funding Announcements:  Investigators interested in seeking funding for COVID-19-related research consistent with AHRQ’s priorities can use their general funding announcements. In addition, AHRQ grantees are encouraged to contact their project officers with novel ideas for implementation and future research.

Centers for Disease Control and Prevention

Department of Defense

  • DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research: The USAMRDC’s mission is to provide solutions to medical problems of importance to the American Service Member at home and abroad, as well as to the general public at large. Research areas of interest include:  Military Infectious Diseases Research Program, Combat Casualty Care Research Program, Military Operational Medicine Research Program, Medical Biological Defense Research Program, and Medical Chemical Defense Research Program. Requires a pre-proposal befor being approved for a full application.
    Funding Opportunity Number: HT9425-23-S-BAA1
    Due Date: Active until 09/30/2027
    Funding Amount: No set limit

National Institutes of Health

National Science Foundation

National Science Foundation

wdt_ID Sponsor Program Funding Deadline
5 NSF (NSF 22-620) Ecology and Evolution of Infectious Diseases* $3,000,000 total 11/16/2022 & third Wednesday annually thereafter
11 NSF (NSF 20-579) Dynamics of Integrated Socio-Environmental Systems (DISES) (20-579 ) DISES Research Projects: $1,600,000
DISES-RCN Awards: $500,000
11/15/2023 & annually thereafter
13 NSF (NSF 22-077) Sentinel Systems that Detect, Recognize, Actuate, and Mitigate Emergent Biological Threats (DREAM Sentinels) $3,000,000 will be allocated annually Rolling deadlines
17 NSF (NSF 22-565) Civic Innovation Challenge (CIVIC) Stage 2 Full Award: $1,000,000
(CIVIC includes COVID as a disaster: see NSF 20-100))
Stage 2: 03/01/2023 (only if funded with Stage 1)

Patient-Centered Outcomes Research Institute

  • Broad Pragmatic Studies Funding Announcement — 2023 Standing PFA. This PCORI Announcement invites applications for high-quality comparative clinical effectiveness research projects that align the proposed research with at least one of the 4 National Priorities for Health: improving outcomes for people with intellectual and developmental disabilities, preventing maternal morbidity and mortality, COVID-19, and rare disease. Eight topic themes are also introduced in this funding opportunity: (A) Populations: (1) Promoting healthy children and youth; (2) Promoting health of older adults. (B) Health Behavior: (3) Addressing violence and trauma; (4) Addressing substance use. (C) Health Conditions: (5) Improving cardiovascular health; (6) Managing pain; (7) Promoting sleep health; (8) Improving mental and behavioral health.
    Letter of Intent Due: Cycle 1: February 7, 2023
    Due Date: Cycle 1: May 2, 2023
    Funding: Category 1: Less than or equal to $5 million direct costs; Category 2: Greater than $5 million; up to $10 million direct costs

Internal UW-Madison Funding Opportunities

UWCCC BioBank – COVID 19-Related Blood Samples for Research

Internal UW-Madison Opportunities

wdt_ID Sponsor Program Funding Deadline
1 Wisconsin Partnership Program Wisconsin Partnership Program Varies by type of program See website for annual due dates
4 UWCCC Translational Science BioCore BioBank, UW SMPH & Wisconsin Partnership Program COVID-19 BioBank Initiative Request for Proposals Access to UWCCC BioBank resources (samples, clinical or survey data) to further COVID-19 research efforts Applications reviewed monthly, and approvals granted on a rolling basis
6 UW ICTR Novel Methods Award $50,000 Letter of Intent due 11/18/2022; Full Application due: 12/19/2022
7 UW ICTR Clinical & Community Outcomes Research $75,000 Letter of Intent Due: 11/23/2022; Full Application Due: 1/11/2023
8 UW ICTR Collaborative Health Equity Research $50,000 Letter of Intent Due: 11/23/2022; Full Application Due: 1/11/2023
9 UW ICTR Evidence to Implementation $75,000 Pre-Proposal: 7/15/2022; Final Application: 9/12/2022
10 UW ICTR Marshfield Clinic/Marshfield Clinic-UW Award Track 1: $50,000
Track 2: $100,000
Letter of Intent: 8/19/2022; Application Due: 9/16/2022
11 UW ICTR Stakeholder and Patient Engaged Research $100,000 Letter of Intent Due: 11/23/2022; Full Application Due: 1/11/2023
12 UW ICTR Translational Basic & Clinical Research Pilot Awards $50,000 Letter of Intent Due: 12/19/2022; Full Application Due: 2/06/2023
13 Wisconsin Alumni Research Foundation Fall Research Competition Average award is about $60,000 September annually